Business Description
Arcoma AB
ISIN : SE0006219176
Total Employee Number:
31Compare
Compare
Traded in other countries / regions
ARCOMA.Sweden IPO Date
2014-11-14Description
Arcoma AB provides digital radiography systems in Sweden. It offers products including wireless flat panel detectors, positioning devices, and precision dr systems.
Financial Strength
10/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Cash-To-Debt | No Debt | |||||
Equity-to-Asset | 0.74 | |||||
Interest Coverage | 40.94 | |||||
Piotroski F-Score | 5/9 | |||||
Altman Z-Score | 4.69 | |||||
Beneish M-Score | -3.34 | |||||
WACC vs ROIC | ||||||
Growth Rank
4/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
3-Year Revenue Growth Rate | -1.2 | |||||
3-Year EBITDA Growth Rate | 9.6 | |||||
3-Year EPS without NRI Growth Rate | 35.7 | |||||
3-Year Book Growth Rate | 14.5 | |||||
Future 3-5Y EPS without NRI Growth Rate Estimate Industry Rank | 33.17 | |||||
Future 3-5Y Total Revenue Growth Rate Estimate | 4.44 |
Momentum Rank
8/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
5-Day RSI | 29.55 | |||||
9-Day RSI | 37.33 | |||||
14-Day RSI | 41.53 | |||||
3-1 Month Momentum % | 3.4 | |||||
6-1 Month Momentum % | 11.81 | |||||
12-1 Month Momentum % | -12.16 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Current Ratio | 3.12 | |||||
Quick Ratio | 2.14 | |||||
Cash Ratio | 1.29 | |||||
Days Inventory | 127.29 | |||||
Days Sales Outstanding | 52.94 | |||||
Days Payable | 86 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
3-Year Average Share Buyback Ratio | -2.8 |
Profitability Rank
6/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Gross Margin % | 39.85 | |||||
Operating Margin % | 3.61 | |||||
Net Margin % | 2.99 | |||||
EBITDA Margin % | 9.34 | |||||
FCF Margin % | 12.3 | |||||
OCF Margin % | 16.16 | |||||
ROE % | 5.48 | |||||
ROA % | 4.04 | |||||
ROIC % | 6.96 | |||||
3-Year ROIIC % | -9.99 | |||||
ROC (Joel Greenblatt) % | 21.46 | |||||
ROCE % | 7.01 | |||||
Years of Profitability over Past 10-Year | 6 |
GF Value Rank
7/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
PE Ratio | 29.78 | |||||
Forward PE Ratio | 14.65 | |||||
PE Ratio without NRI | 29.78 | |||||
Price-to-Owner-Earnings | 7.79 | |||||
PS Ratio | 0.89 | |||||
PB Ratio | 1.53 | |||||
Price-to-Tangible-Book | 1.95 | |||||
Price-to-Free-Cash-Flow | 7.09 | |||||
Price-to-Operating-Cash-Flow | 5.43 | |||||
EV-to-EBIT | 18.77 | |||||
EV-to-Forward-EBIT | 13.4 | |||||
EV-to-EBITDA | 7.69 | |||||
EV-to-Forward-EBITDA | 8.46 | |||||
EV-to-Revenue | 0.72 | |||||
EV-to-Forward-Revenue | 0.95 | |||||
EV-to-FCF | 5.85 | |||||
Price-to-GF-Value | 1.02 | |||||
Price-to-Projected-FCF | 1.18 | |||||
Price-to-Median-PS-Value | 0.9 | |||||
Price-to-Graham-Number | 1.61 | |||||
| Price-to-Net-Current-Asset-Value | 2.07 | |||||
| Price-to-Net-Cash | 15.17 | |||||
Earnings Yield (Greenblatt) % | 5.33 | |||||
FCF Yield % | 13.58 |
Operating Revenue by Business Segment
Operating Revenue by Geographic Region
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Arcoma AB Executives
DetailsAnalyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil kr) | 127.055 | ||
| EPS (TTM) (kr) | 0.27 | ||
| Beta | 0.8251 | ||
| 3-Year Sharpe Ratio | 0.12 | ||
| 3-Year Sortino Ratio | 0.18 | ||
| Volatility % | 39.3 | ||
| 14-Day RSI | 41.53 | ||
| 14-Day ATR (kr) | 0.586536 | ||
| 20-Day SMA (kr) | 8.623 | ||
| 12-1 Month Momentum % | -12.16 | ||
| 52-Week Range (kr) | 6.16 - 11 | ||
| Shares Outstanding (Mil) | 14.31 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 5 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Arcoma AB Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Arcoma AB Stock Events
| Event | Date | Price (kr) | ||
|---|---|---|---|---|
| Third quarter earnings results for 2026 | 2026-10-22 | In 100 days | ||
| Second quarter earnings results for 2026 | 2026-08-20 | In 37 days | ||
| General meeting for 2026 | 2026-05-20 13:00 | 8.50 (+4.68%) | ||
| First quarter earnings results for 2026 | 2026-04-23 | 7.62 (-5.46%) | ||
| Annual report for 2025 | 2026-04-14 | 8.24 (-1.20%) | ||
| Fourth quarter earnings results for 2025 | 2026-02-12 | 7.22 (-5.74%) | ||
| Third quarter earnings results for 2025 | 2025-10-23 | 9.30 (+4.26%) | ||
| Second quarter earnings results for 2025 | 2025-08-21 | 9.16 (-1.93%) | ||
| General meeting for 2025 | 2025-05-14 13:00 | 9.30 (+0.65%) | ||
| First quarter earnings results for 2025 | 2025-04-29 | 8.80 (-3.08%) |
Show
Entries
Arcoma AB Frequently Asked Questions
What is Arcoma AB(OSTO:ARCOMA)'s stock price today?
The current price of OSTO:ARCOMA is kr8.04. The 52 week high of OSTO:ARCOMA is kr11.00 and 52 week low is kr6.16.
When is next earnings date of Arcoma AB(OSTO:ARCOMA)?
The next earnings date of Arcoma AB(OSTO:ARCOMA) is 2026-08-20.
Does Arcoma AB(OSTO:ARCOMA) pay dividends? If so, how much?
Arcoma AB(OSTO:ARCOMA) does not pay dividend.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Articles on Arcoma AB
No articles.
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers